Intellia Therapeutics, Inc. (NTLA)

13.82 +0.22 (+1.58%) USD  |  NASDAQ  |  Mar 04, 16:00
13.89 +0.07 (+0.51%) After-Hours: 07:17
More

Intellia Therapeutics EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Beam Therapeutics, Inc. --
Personalis, Inc. --
Recursion Pharmaceuticals, Inc. --
Pacific Biosciences of California, Inc. --
Twist Bioscience Corp. --